Research & Development



  陳銅苦笑一聲道︰“老漢已經試過很多種墨了,松煙墨,碳墨都不成,不怕侯爺笑話,老漢連鍋底灰都試過了。”   夏日的草原上野花開的爛漫,劉陵提著裙裾在柔軟的草原上漫步,她的頭上戴著一個色彩斑斕的花環,烏黑的長發柔順的披在背後,偶爾俯身摘下一朵漂亮的野花,繼續裝點自己的花冠。啪啪啪视频   雲瑯笑道︰“你覺得我很有擔當?”超碰在线   只要是真正的官僚,必然有唾面自干的本事,桑弘羊的行為就充分說明了這個問題。   左吳拱手道︰“再听下去,大閼氏就會思鄉了。”超碰在线视频   “慢慢來,且讓這個狗賊得意幾天,只要有機會,我們兄弟聯手一起弄死他!”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo